| |
| |
|
| Insider
Information: |
Bozigian Haig P. |
| Relationship: |
Chief Development Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
157,651 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,222,978 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,651 |
|
|
| Total
Value |
$21,222,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-08-05 |
4 |
AS |
$15.00 |
$165,015 |
D/D |
(11,001) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2011-02-28 |
4 |
AS |
$6.83 |
$84,085 |
D/D |
(12,320) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2009-03-30 |
4 |
AS |
$3.43 |
$43,780 |
D/D |
(12,774) |
29,423 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-08-21 |
4 |
AS |
$15.01 |
$210,552 |
D/D |
(13,999) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2010-03-01 |
4 |
AS |
$2.53 |
$35,589 |
D/D |
(14,090) |
55,940 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-17 |
4 |
AS |
$22.51 |
$337,695 |
D/D |
(15,002) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-17 |
4 |
OE |
$2.59 |
$38,855 |
D/D |
15,002 |
93,581 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-13 |
4 |
AS |
$82.56 |
$1,426,628 |
D/D |
(17,268) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-13 |
4 |
OE |
$19.59 |
$357,469 |
D/D |
17,268 |
143,408 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-24 |
4 |
OE |
$19.59 |
$342,551 |
D/D |
17,486 |
159,462 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-24 |
4 |
AS |
$80.03 |
$1,399,434 |
D/D |
(17,486) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-31 |
4 |
AS |
$85.02 |
$1,640,581 |
D/D |
(19,297) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-31 |
4 |
OE |
$19.59 |
$378,028 |
D/D |
19,297 |
161,273 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-20 |
4 |
AS |
$12.30 |
$255,651 |
D/D |
(20,769) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-08-04 |
4 |
AS |
$50.00 |
$1,125,000 |
D/D |
(22,500) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2013-06-21 |
4 |
AS |
$12.50 |
$303,375 |
D/D |
(23,962) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-01-07 |
4 |
AS |
$17.50 |
$437,500 |
D/D |
(25,000) |
76,954 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
• – – |
2014-01-17 |
4 |
OE |
$2.59 |
$77,400 |
D/D |
25,000 |
103,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
• – – |
2014-01-17 |
4 |
AS |
$20.00 |
$500,000 |
D/D |
(25,000) |
78,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2015-10-16 |
4 |
AS |
$47.78 |
$1,194,500 |
D/D |
(25,000) |
106,829 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-09-06 |
4 |
AS |
$60.00 |
$1,575,000 |
D/D |
(26,250) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-09-06 |
4 |
OE |
$8.65 |
$350,138 |
D/D |
26,250 |
140,851 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-07 |
4 |
AS |
$110.00 |
$3,238,132 |
D/D |
(29,399) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-07 |
4 |
OE |
$5.76 |
$371,105 |
D/D |
29,399 |
151,043 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
